bluuebunny/crossref_metadata_2025_split huggingface dataset:
Modulation of macrophage differentiation and activation by decoy receptor 3
Authors: Chang Yung-Chi , Hsu Tsui-Ling , Lin Hsi-Hsien , Chio Chung-Ching , Chiu Allen W , Chen Nien-Jung , Lin Chi-Hung , Hsieh Shie-Liang 
Published: December 2003

AbstractDecoy receptor 3 (DcR3) is a soluble receptor of the tumor necrosis factor receptor superfamily and is readily detected in certain cancer patients. Recently, we demonstrated that DcR3.Fc-treated dendritic cells skew T cell responses to a T helper cell type 2 phenotype. In this study, we further asked its ability to modulate CD14+ monocyte differentiation into macrophages induced by macrophage-colony stimulating factor in vitro. We found that DcR3.Fc was able to modulate the expression of several macrophage markers, including CD14, CD16, CD64, and human leukocyte antigen-DR. In contrast, the expression of CD11c, CD36, CD68, and CD206 (mannose receptor) was not affected in the in vitro culture system. Moreover, phagocytic activity toward immune complexes and apoptotic bodies as well as the production of free radicals and proinflammatory cytokines in response to lipopolysaccharide were impaired in DcR3.Fc-treated monocyte-derived macrophages. This suggests that DcR3.Fc might have potent, suppressive effects to down-regulate the host-immune system.
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
Authors: Tournigand Christophe , André Thierry , Achille Emmanuel , Lledo Gérard , Flesh Michel , Mery-Mignard Dominique , Quinaux Emmanuel , Couteau Corinne , Buyse Marc , Ganem Gérard , Landi Bruno , Colin Philippe , Louvet Christophe , de Gramont Aimery 
Published: December 2003

Purpose In metastatic colorectal cancer, phase III studies have demonstrated the superiority of fluorouracil (FU) with leucovorin (LV) in combination with irinotecan or oxaliplatin over FU + LV alone. This phase III study investigated two sequences: folinic acid, FU, and irinotecan (FOLFIRI) followed by folinic acid, FU, and oxaliplatin (FOLFOX6; arm A), and FOLFOX6 followed by FOLFIRI (arm B). Patients and Methods Previously untreated patients with assessable disease were randomly assigned to receive a 2-hour infusion of l-LV 200 mg/m2 or dl-LV 400 mg/m2 followed by a FU bolus 400 mg/m2 and 46-hour infusion 2,400 to 3,000 mg/m2 every 46 hours every 2 weeks, either with irinotecan 180 mg/m2 or with oxaliplatin 100 mg/m2 as a 2-hour infusion on day 1. At progression, irinotecan was replaced by oxaliplatin (arm A), or oxaliplatin by irinotecan (arm B). Results Median survival was 21.5 months in 109 patients allocated to FOLFIRI then FOLFOX6 versus 20.6 months in 111 patients allocated to FOLFOX6 then FOLFIRI (P = .99). Median second progression-free survival (PFS) was 14.2 months in arm A versus 10.9 in arm B (P = .64). In first-line therapy, FOLFIRI achieved 56% response rate (RR) and 8.5 months median PFS, versus FOLFOX6 which achieved 54% RR and 8.0 months median PFS (P = .26). Second-line FOLFIRI achieved 4% RR and 2.5 months median PFS, versus FOLFOX6 which achieved 15% RR and 4.2 months PFS. In first-line therapy, National Cancer Institute Common Toxicity Criteria grade 3/4 mucositis, nausea/vomiting, and grade 2 alopecia were more frequent with FOLFIRI, and grade 3/4 neutropenia and neurosensory toxicity were more frequent with FOLFOX6. Conclusion Both sequences achieved a prolonged survival and similar efficacy. The toxicity profiles were different.
Evaluation of Insulin Sensitivity in Healthy Volunteers Treated with Olanzapine, Risperidone, or Placebo: A Prospective, Randomized Study Using the Two-Step Hyperinsulinemic, Euglycemic Clamp
Authors: Sowell Margaret , Mukhopadhyay Nitai , Cavazzoni Patrizia , Carlson Christopher , Mudaliar Sunder , Chinnapongse Sithiphol , Ray Amy , Davis Trent , Breier Alan , Henry Robert R. , Dananberg Jamie 
Published: December 2003

Abstract
The primary objective of this study was to evaluate insulin sensitivity in healthy subjects treated with olanzapine or risperidone. Subjects were randomly assigned to single-blind therapy with olanzapine (10 mg/d), risperidone (4 mg/d), or placebo for approximately 3 wk. Insulin sensitivity was assessed pre- and posttreatment using a 2-step, hyperinsulinemic, euglycemic clamp. Glucose and insulin responses were also assessed by a mixed meal tolerance test. Of the 64 subjects randomized, 22, 14, and 19 in the olanzapine, risperidone, and placebo groups, respectively, completed the study procedures. There were no significant within-group changes in the glucose disposal rate or the insulin sensitivity index for the active therapy groups. Further, the results of the mixed meal tolerance test did not demonstrate clinically significant changes in integrated glucose metabolism during treatment with these medications. In summary, this study did not demonstrate significant changes in insulin sensitivity in healthy subjects after 3 wk of treatment with olanzapine or risperidone.
Association of the (TAAAA)n Repeat Polymorphism in the Sex Hormone-Binding Globulin (SHBG) Gene with Polycystic Ovary Syndrome and Relation to SHBG Serum Levels
Authors: Xita Nectaria , Tsatsoulis Agathocles , Chatzikyriakidou Anthi , Georgiou Ioannis 
Published: December 2003

Abstract
SHBG levels are frequently low in women with polycystic ovary syndrome (PCOS) and may contribute to increased tissue exposure to free androgens. A (TAAAA)n repeat polymorphism in the promoter of the SHBG gene has been described recently, and its transcriptional activity has been shown to be related to the number of tandem repeats. Recent evidence also suggests that prenatal exposure to androgen excess may program for the development of the PCOS phenotype during adulthood. Our aim was to investigate the possible association of the functional (TAAAA)n polymorphism in the promoter of the SHBG gene with PCOS and its relation to SHBG levels. We studied 185 women with PCOS and 324 normal controls. Genotype analysis revealed six (TAAAA)n alleles containing 6–11 repeats. The distribution of these alleles was different in the two groups. Women with PCOS had a significantly greater frequency of longer (TAAAA)n alleles (more than eight repeats) than normal women who had shorter alleles (less than eight repeats) in higher frequency (P = 0.001). Furthermore, in the PCOS group, carriers of the longer allele genotypes had lower SHBG levels [1.17 ± 0.68 μg/dl (35.1 ± 20.5 nmol/liter)] than those with shorter alleles [1.51 ± 0.93 μg/dl (45.3 ± 28 nmol/liter P = 0.02). A novel (TAAAA)n allele, which has not been previously reported, was found in low frequency, mainly in the control population. From these results, there is evidence that there may be a genetic contribution to decreased SHBG levels frequently seen in women with PCOS. The SHBG gene may act as a susceptibility gene for PCOS and may provide the genetic link for the developmental origin hypothesis for PCOS that was recently proposed on the basis of experimental observation in prenatally androgenized sheep and primates.
Genetic Polymorphism PC-1 K121Q and Ethnic Susceptibility to Insulin Resistance
Authors: Abate Nicola , Carulli Lucia , Cabo-Chan Alberto , Chandalia Manisha , Snell Peter G. , Grundy Scott M. 
Published: December 2003

Abstract
Genetic susceptibility may be responsible for high prevalence of insulin resistance in Asian Indians. This study was carried out in samples of local Asian Indians and Caucasians to determine whether plasma cell membrane glycoprotein (PC)-1 K121Q and insulin receptor substrate-1 (IRS-1) G972A polymorphisms contribute significantly to susceptibility to insulin resistance in Asian Indians. The frequency of carrying at least one copy of the PC-1 121Q variant in Asian Indians was significantly higher than that in Caucasians (P = 0.01), but the frequency was similar for IRS-1 972A (6% and 7%). A significantly higher insulin area under the curve during oral glucose tolerance testing (P &lt; 0.0001) and lower insulin sensitivity during hyperinsulinemic-euglycemic clamps (P = 0.04) were found in Asian Indians with PC-1 121Q variant compared with Asian Indians with wild-type PC-1 and with Caucasians with or without the polymorphism. IRS-1 972A was not associated with any change in insulin sensitivity. We conclude that the PC-1 K121Q polymorphism associates with primary insulin resistance in migrant Asian Indians. A relatively high frequency of this polymorphism thus may be one factor contributing to insulin resistance susceptibility in Asian Indians. This finding indicates the need for expanded studies on the association between PC-1 K121Q and insulin resistance in a representative sample of the Asian Indian population.
Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest
Authors: Pigny Pascal , Merlen Emilie , Robert Yann , Cortet-Rudelli Christine , Decanter Christine , Jonard Sophie , Dewailly Didier 
Published: December 2003

Abstract
The serum level of anti-Mullerian hormone (AMH), a product from granulosa cells involved in follicle growth, has been shown to correlate tightly with the small antral follicle number (FN) at ultrasonography (U/S) in women who do not have polycystic ovary syndrome (PCOS). Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS. Serum AMH has been assayed in 104 women (59 symptomatic PCOS, 45 controls) between d 2 and 7 after the last either spontaneous or progestin-induced (in PCOS) menstrual period. Mean serum AMH level was markedly increased in the PCOS group (47.1 ± 22.9 vs. 20.8 ± 11.6 pmol/liter in controls; P &lt; 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 ± 8.3 vs. 4.8 ± 1.9; P &lt; 0.0001, respectively). The ratio AMH/FN was similar between the two groups (4.8 ± 3.4 vs. 4.8 ± 2.9; P = 0.55). By simple regression, both in PCOS and controls, the AMH level was positively related to the 2- to 5-mm FN at U/S (P &lt; 0.0001 and P &lt; 0.03, respectively), but not to the 6- to 9-mm FN, and was negatively correlated to the serum FSH level (P &lt; 0.02 and P &lt; 0.04, respectively). AMH was also positively related to the serum testosterone and androstenedione levels, in PCOS exclusively (P &lt; 0.0005 and &lt;0.002, respectively). No relationship was found between AMH and age, serum estradiol, inhibin B, and LH levels in both groups. After multiple regression only the 2- to 5-mm FN remained significantly related to AMH in PCOS whereas testosterone, androstenedione, and FSH were no longer. In conclusion, the assay of the serum AMH may represent an important breakthrough in the diagnosis and in the understanding of PCOS. Our data suggest that the increase of AMH serum level in PCOS is the consequence of the androgen-induced excess in small antral FN and that each follicle produces a normal amount of AMH. We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection.
Lack of Efficacy of Fadrozole in Treating Precocious Puberty in Girls with the McCune-Albright Syndrome
Authors: Nunez Susan B. , Calis Karim , Cutler Gordon B. , Jones Janet , Feuillan Penelope P. 
Published: December 2003

Abstract
We administered the aromatase inhibitor fadrozole to 16 girls with gonadotropin-independent precocious puberty due to the McCune-Albright syndrome. The girls’ ages ranged from 3.2–9.7 yr, and their bone ages ranged from 5.75–14.25 yr. After baseline evaluations, fadrozole was started at a dose of 240 μg/kg·d (equivalent to the dose recommended for therapy of estrogen-dependent breast cancer) for 12–21 months and increased to 480 μg/kg·d for an additional 12 months in 10 girls. During treatment, seven girls had evidence of central precocious puberty; hence, the GnRH agonist deslorelin (4 μg/kg·d sc) was added to their regimen. One girl was on a long-acting GnRH agonist from the start of treatment. Patients were evaluated at 2–6-month intervals throughout treatment. After the first 6–12 months of treatment, fadrozole showed some benefits in 10 girls, including decrease in frequency of menses and/or rates of linear growth and bone maturation; however, fadrozole had no significant benefit in the group as a whole. The seven girls with evidence of central precocious puberty had no slowing in the progression of their puberty during the combined fadrozole and GnRH analog treatment. Adverse effects of fadrozole included inhibition of cortisol and aldosterone biosynthesis at the dose of 480 μg/kg·d, without clinical evidence of adrenal insufficiency. In addition, three patients complained of nonspecific abdominal pain during fadrozole treatment. In one patient, this resolved with a reduction in dose from 480 to 240 μg/kg·d; in two patients, it resolved spontaneously. One girl had muscle weakness and constipation on the 480 μg/kg·d. This resolved after discontinuation of the drug. We conclude that fadrozole is not sufficiently potent to block estrogen synthesis in most girls with gonadotropin-independent precocious puberty due to the McCune-Albright syndrome and may impair the adrenocortical stress response.
Abnormal Sympathoadrenal Activity, but Normal Energy Expenditure in Hypopituitarism
Authors: Mersebach Henriette , Svendsen Ole Lander , Astrup Arne , Feldt-Rasmussen Ulla 
Published: December 2003

Abstract
In this study of 23 hypopituitary patients and 26 healthy controls, we have addressed whether the obese state of substituted hypopituitary patients is facilitated by abnormal sympathoadrenal activity or energy expenditure (EE). All patients received adequate substitution therapy including GH therapy. The investigation program included assessment of sympathoadrenal activity (urinary catecholamines), body composition (dual-energy x-ray absorptiometry), appetite sensations (visual analog scale), and EE (indirect calorimetry in respiration chamber). Twenty-four-hour urinary epinephrine adjusted for lean body mass and fat mass was significantly lower in patients compared with controls. GH and hydrocortisone were single negative predictors of urinary epinephrine. The major determinants of EE in patients were lean body mass and fat mass, explaining 96, 95, and 80% of the variance in 24-h EE, sleeping EE, and basal metabolic rate, respectively. Addition of urinary catecholamines explained another 1–4% of the variance in 24-h EE and basal metabolic rate, respectively. Lean patients exhibited significantly more hunger than obese patients and lean controls. In conclusion, hypopituitary patients have lower sympathoadrenal activity but normal EE, compared with healthy controls. This may reflect a central defect in hypopituitarism, however the possible impact of long-term GH and hydrocortisone treatment requires further attention.
Decreased Fatty Acid β-Oxidation in Riboflavin-Responsive, Multiple Acylcoenzyme A Dehydrogenase-Deficient Patients Is Associated with an Increase in Uncoupling Protein-3
Authors: Russell Aaron P. , Schrauwen Patrick , Somm Emmanuel , Gastaldi Giacomo , Hesselink Matthijs K. C. , Schaart Gert , Kornips Esther , Lo Sing Kai , Bufano Daniela , Giacobino Jean-Paul , Muzzin Patrick , Ceccon Mara , Angelini Corrado , Vergani Lodovica 
Published: December 2003

Abstract
Riboflavin-responsive, multiple acylcoenzyme A dehydrogenase deficiency (RR-MAD), a lipid storage myopathy, is characterized by, among others, a decrease in fatty acid (FA) β-oxidation capacity. Muscle uncoupling protein 3 (UCP3) is up-regulated under conditions that either increase the levels of circulating free FA and/or decrease FA β-oxidation. Using a relatively large cohort of seven RR-MAD patients, we aimed to better characterize the metabolic disturbances of this disease and to explore the possibility that it might increase UCP3 expression. A battery of biochemical and molecular tests were performed, which demonstrated decreases in FA β-oxidation and in the activities of respiratory chain complexes I and II. These metabolic alterations were associated with increases of 3.1- and 1.7-fold in UCP3 mRNA and protein expression, respectively. All parameters were restored to control values after riboflavin treatment. We postulate that the up-regulation of UCP3 in RR-MAD is due to the accumulation of muscle FA/acylCoA. RR-MAD is an optimal model to support the hypothesis that UCP3 is involved in the outward translocation of an excess of FA from the mitochondria and to show that, in humans, the effects of FA on UCP3 expression are direct and independent of fatty acid β-oxidation.
Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of Recombinant Resistin on Lipid and Glucose Metabolism in Human Differentiated Adipocytes
Authors: McTernan Philip G. , Fisher FFolliott M. , Valsamakis George , Chetty Rajkumar , Harte Alison , McTernan Claire L. , Clark Penny M. S. , Smith Stephen A. , Barnett Anthony H. , Kumar Sudhesh 
Published: December 2003

AbstractResistin, an adipocyte secreted factor, has been suggested to link obesity with type 2 diabetes in rodent models, but its relevance to human diabetes remains uncertain. Although previous studies have suggested a role for this adipocytokine as a pathogenic factor, its functional effects, regulation by insulin, and alteration of serum resistin concentration by diabetes status remain to be elucidated. Therefore, the aims of this study were to analyze serum resistin concentrations in type 2 diabetic subjects; to determine the in vitro effects of insulin and rosiglitazone (RSG) on the regulation of resistin, and to examine the functional effects of recombinant human resistin on glucose and lipid metabolism in vitro. Serum concentrations of resistin were analyzed in 45 type 2 diabetic subjects and 34 nondiabetic subjects. Subcutaneous human adipocytes were incubated in vitro with insulin, RSG, and insulin in combination with RSG to examine effects on resistin secretion. Serum resistin was increased by approximately 20% in type 2 diabetic subjects compared with nondiabetic subjects (P = 0.004) correlating with C-reactive protein. No other parameters, including adiposity and fasting insulin levels, correlated with serum resistin in this cohort. However, in vitro, insulin stimulated resistin protein secretion in a concentration-dependent manner in adipocytes [control, 1215 ± 87 pg/ml (mean ± sem); 1 nm insulin, 1414.0 ± 89 pg/ml; 1 μm insulin, 1797 ± 107 pg/ml (P &lt; 0.001)]. RSG (10 nm) reduced the insulin-mediated rise in resistin protein secretion (1 nm insulin plus RSG, 971 ± 35 pg/ml; insulin, 1 μm insulin plus RSG, 1019 ± 28 pg/ml; P &lt; 0.01 vs. insulin alone). Glucose uptake was reduced after treatment with 10 ng/ml recombinant resistin and higher concentrations (P &lt; 0.05). Our in vitro studies demonstrated a small, but significant, reduction in glucose uptake with human recombinant resistin in differentiated preadipocytes. In human abdominal sc adipocytes, RSG blocks the insulin-mediated release of resistin secretion in vitro. In conclusion, elevated serum resistin in human diabetes reflects the subclinical inflammation prevalent in type 2 diabetes. Our in vitro studies suggest a modest effect of resistin in reducing glucose uptake, and suppression of resistin expression may contribute to the insulin-sensitizing and glucose-lowering actions of the thiazolidinediones.
Ultrasonic Torsion Welding of Sheet Metals to Cellular Metallic Materials
Authors: Born C. , Kuckert H. , Wagner G. , Eifler D. 
Published: December 2003

AbstractOne of the most important requirements for finding new applications for cellular metals is to integrate them in complex technical structures. The metal foams have to be joined to each other, or to sheet materials, by suitable joining techniques. The main topics of this paper are the ultrasonic torsion welding of cellular metallic materials to sheet metals and the investigation of the mechanical properties of the joints. The basic materials of foams and sheet metals were different aluminum and iron alloys. Depending on the materials used, weldings with tensile shear strengths of up to 25 MPa were realized. Using aluminum foam sandwich (AFS) and sheet metals, successful weldings were performed before and after the foaming process. Furthermore, it was possible to perform a successful foaming process with the unfoamed AFS/sheet metal joints. Microscopic investigations showed that the ultrasonic welding technique allows the joining of the metal foams with sheet metals without significant deformation of the joining partners. The temperatures during the welding process in the interface were below the melting point of the foams and the sheet metals.
Optical Properties of Functional Hybrid Organic–Inorganic Nanocomposites
Authors: Sanchez C. , Lebeau B. , Chaput F. , Boilot J.‐P. 
Published: December 2003

AbstractFunctional hybrids are nanocomposite materials lying at the interface of organic and inorganic realms, whose high versatility offers a wide range of possibilities to elaborate tailor‐made materials in terms of chemical and physical properties. Because they present several advantages for designing materials for optical applications (versatile and relatively facile chemistry, easy shaping and patterning, materials having good mechanical integrity and excellent optical quality), numerous silica or/and siloxane based hybrid organic–inorganic materials have been developed in the past few years. The most striking examples of functional hybrids exhibiting emission properties (solid‐state dye lasers, rare‐earth doped hybrids, electroluminescent devices), absorption properties (photochromic), nonlinear optical (NLO) properties (second‐order NLO properties, photochemical hole burning (PHB), photorefractivity), and sensing are summarized in this review.
Population Growth of Zooplankton (Rotifers and Cladocerans) Fed Chlorella vulgaris and Scenedesmus acutus in Different Proportions
Authors: Flores‐Burgos J. , Sarma S. S. S. , Nandini S. 
Published: December 2003

AbstractIn the present work we tested the effect of Chlorella vulgaris and Scenedesmus acutus in different proportions on the population growth of Brachionus calyciflorus, Brachionus patulus, Ceriodaphnia dubia, and Moina macrocopa. In general, both rotifer species grew well on either type of algae. Regardless of algal mixture, B. calyciflorus had a shorter initial phase, while B. patulus needed more than a week to begin the exponential phase of growth. Both the rotifer species showed consistently better population growth with Chlorella than on Scenedesmus, or the mixture. At any given algal combination, B. patulus had higher peak values than B. calyciflorus. The rate of population increase (r) for both the rotifers varied from 0.18 to 0.48 d—1 depending on the algal type and combination. Regardless of algal type and combination, B. calyciflorus had a much higher value of r than B. patulus. Both C. dubia and M. macrocopa grew on the algal types, whether offered separately or in mixture. Regardless of the treatment type, C. dubia needed a longer period (about 2 weeks) than M. macrocopa to reach peak abundances. Thus, our study did not support the view that Scenedesmus is consistently superior to Chlorella as a basic diet to the tested species of zooplankton.
Adsorptive Separation of 1, 2‐Dichloroethane from Model Wastewater by Natural Clinoptilolite
Authors: Pilchowski Kurt , Chmielewská Eva 
Published: December 2003

AbstractThe adsorptive separation of 1, 2‐dichloroethane from model wastewater by different Slovak natural and octadecylammonium‐modified clinoptilolites has been studied. It was found that the 1, 2‐dichloroethane will be adsorbed by natural as well as by surfactant‐modified clinoptilolites; all clinoptilolites have a similar adsorption loading. There was also no remarkable difference between the natural and surfactant‐modified clinoptilolites in respect to the adsorption kinetics.